Goodwill and Other Identifiable Intangible Assets

3 Months Ended

Mar. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Identifiable Intangible Assets

The change in the carrying amount of goodwill attributable to each reportable segment for the three months ended March 31, 2017 was as follows:



($ in millions)	Performance Coatings		Industrial Coatings		Total
Balance, December 31, 2016	$	2,870	$	702	$	3,572
Acquisitions	28		7		35
Foreign currency	103		10		113
Balance, March 31, 2017	$	3,001	$	719	$	3,720

A summary of the carrying value of the Company's identifiable intangible assets is as follows:



	March 31, 2017							December 31, 2016
($ in millions)	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Trademarks - indefinite lives	$	1,181	N/A			$	1,181	$	1,107	N/A			$	1,107

Customer-related intangibles	1,319		(648		)	671		1,272		(618		)	654
Acquired technology	$	596	$	(456	)	$	140	$	587	$	(446	)	$	141
Trade names	150		(75		)	75		142		(71		)	71
Other	43		(30		)	13		38		(28		)	10
Balance	$	3,289	$	(1,209	)	$	2,080	$	3,146	$	(1,163	)	$	1,983

The Company’s identifiable intangible assets with finite lives are being amortized over their estimated useful lives. Aggregate amortization expense related to these identifiable intangible assets for the three months ended March 31, 2017 and 2016 was $31 million, and $30 million, respectively.

As of March 31, 2017, estimated future amortization expense of identifiable intangible assets is as follows:



($ in millions)	Future Amortization Expense
Remaining nine months of 2017	$	89
2018	115
2019	100
2020	90
2021	85
2022	85
Thereafter	335

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details